Tetanus in a subcutaneous drug abuser: Ineffectiveness of intrathecal baclofen

4Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This report discusses the issues involved in the diagnosis and management of tetanus. A 29-year-old female with a history of illicit drug use presented with progressive tetany secondary to an abscess on her forearm from subcutaneous injections. She was managed in the intensive care unit for 29 days and was discharged to the ward. The main issue in her management was control of tetanic episodes interfering with ventilation and resistant to intrathecal baclofen. Other therapeutic strategies aimed at reducing spasms included magnesium, atracurium, pancuronium, midazolam, propofol and dantrolene. We conducted searches on Medline, PUBMED and the Cochrane Database of Systematic Reviews using the following terms: tetanus, treatment, therapy, drug abuse, magnesium, baclofen and human anti-tetanus immunoglobulin (hAIG). The current strategies involved in treating tetanus are discussed.

Cite

CITATION STYLE

APA

Thomas, R. M., & Bellamy, M. C. (2006). Tetanus in a subcutaneous drug abuser: Ineffectiveness of intrathecal baclofen. Anaesthesia and Intensive Care, 34(6), 811–815. https://doi.org/10.1177/0310057x0603400603

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free